Alkermes (ALKS) Total Liabilities (2010 - 2026)
Alkermes (ALKS) reported Total Liabilities of $2.5 billion for Q1 2026, up 339.44% year-over-year from $570.4 million in Q1 2025, and up 275.4% quarter-over-quarter from $667.7 million in Q4 2025.
Alkermes (ALKS) Total Liabilities (2010 - 2026) Analysis & Trends
Alkermes (ALKS) has 17 years of Total Liabilities data on file, last reported at $2.5 billion in Q1 2026.
- Total Liabilities for Q1 2026 came in at $2.5 billion, up 339.44% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.5 billion (up 339.44% YoY), and the FY2025 annual result was $667.7 million, up 13.06% from the prior year.
- Total Liabilities improved to $2.5 billion in Q1 2026 per ALKS's latest filing, from $667.7 million in the prior quarter.
- Over five years, Total Liabilities peaked at $2.5 billion in Q1 2026 and troughed at $570.4 million in Q1 2025.
- A 5-year average of $911.3 million and a median of $899.0 million in 2022 frame the typical range for Total Liabilities.
- The sharpest annual moves came in 2024 and 2026: Total Liabilities sank 36.74% in 2024, then jumped 339.44% in 2026.
- A 5-year view of Total Liabilities shows it stood at $920.2 million in 2022, then grew by 1.45% to $933.5 million in 2023, then slumped by 36.74% to $590.6 million in 2024, then rose by 13.06% to $667.7 million in 2025, then soared by 275.4% to $2.5 billion in 2026.
- Business Quant data shows ALKS's Total Liabilities at $2.5 billion in Q1 2026, $667.7 million in Q4 2025, and $596.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 31.81 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 11.92 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 813.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 148.77 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 1.50 Bn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 6.72 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 2.51 Bn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 1.13 Bn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 1.82 Bn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 292.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.51 Bn |
| Dec 31, 2025 | 667.70 Mn |
| Sep 30, 2025 | 596.08 Mn |
| Jun 30, 2025 | 628.23 Mn |
| Mar 31, 2025 | 570.39 Mn |
| Dec 31, 2024 | 590.59 Mn |
| Sep 30, 2024 | 863.19 Mn |
| Jun 30, 2024 | 922.84 Mn |
| Mar 31, 2024 | 869.13 Mn |
| Dec 31, 2023 | 933.54 Mn |
| Sep 30, 2023 | 923.65 Mn |
| Jun 30, 2023 | 906.75 Mn |
| Mar 31, 2023 | 917.15 Mn |
| Dec 31, 2022 | 920.23 Mn |
| Sep 30, 2022 | 899.05 Mn |
| Jun 30, 2022 | 875.09 Mn |
| Mar 31, 2022 | 902.46 Mn |
| Dec 31, 2021 | 911.90 Mn |
| Sep 30, 2021 | 899.26 Mn |
| Jun 30, 2021 | 839.67 Mn |